Nightingale Health acquires all intellectual property assets of the Velvet™ blood collection device and secures its position as the sole provider of a fully integrated remote health check solution
Nightingale Health Plc Press release 27 June 2024 at 2:45 p.m. (EEST) Nightingale Health Plc, a pioneer in disease risk detection and preventative health, announced it has acquired all intellectual property assets from RenegadeXBio, PBC related to the Velvet™ blood collection device. The acquisition of the intellectual property assets, previously owned by Weavr Health Corp, changes Nightingale Health’s position from license holder to having the full and exclusive ownership and control over the Velvet™ device. High quality blood self-collection capability is a strategic